+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptide Synthesis Market - Global Forecast 2026-2032- Product Image
Peptide Synthesis Market - Global Forecast 2026-2032- Product Image
Sale

Peptide Synthesis Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896703
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Peptide Synthesis Market is projected to reach USD 811.94 Million in 2026. It is expected to continue growing at a CAGR of 8.12%, reaching USD 1.30 Billion by 2032.

Peptide synthesis is moving from a specialized research service into a strategic biomanufacturing capability for pharmaceuticals, diagnostics, vaccines, cosmetics, and advanced materials. Demand is being reinforced by clinically validated peptide therapeutics, especially in metabolic disorders, oncology, antimicrobial applications, and rare diseases, where peptides offer high target specificity, predictable degradation, and tunable pharmacokinetics.

The market is shaped by solid-phase peptide synthesis, liquid-phase synthesis, hybrid approaches, recombinant peptide production, purification technologies, and GMP-compliant contract development and manufacturing operations. Industry leaders are prioritizing high-purity peptide APIs, scalable synthesis of long and modified sequences, greener solvents, supply assurance, and faster analytical release to support commercial launches and complex clinical pipelines.

Transformative Shifts in the Peptide Synthesis Landscape

The peptide synthesis landscape is being transformed by the rapid commercialization of peptide drugs, the expansion of GLP-1 and multi-agonist metabolic therapies, and the need for manufacturing platforms that can scale complex molecules from milligrams to multi-kilogram GMP batches. This shift is intensifying investment in automated synthesizers, high-throughput purification, process analytical technology, and specialized development and manufacturing capacity.

At the same time, regulatory expectations for impurity profiling, nitrosamine risk management, extractables and leachables, and data integrity are raising the performance bar. Companies are responding with platformized SPPS workflows, orthogonal analytical methods such as LC-MS and HPLC, improved resin and coupling chemistries, and solvent-reduction initiatives to improve cost, quality, and environmental performance.

Cumulative Impact of Artificial Intelligence on Peptide Synthesis

Artificial intelligence is becoming a practical accelerator across peptide discovery, developability assessment, synthesis planning, and quality control. AI models help screen peptide libraries, predict binding affinity, flag aggregation and solubility risks, suggest sequence modifications, and prioritize candidates with stronger stability and lower immunogenicity risk before expensive laboratory work begins.

In manufacturing, machine learning supports route optimization, impurity prediction, chromatographic method development, batch monitoring, and deviation prevention. The strongest near-term value comes from combining AI with verified experimental datasets, electronic laboratory notebooks, and GMP-compliant validation; AI improves decision speed, but regulated peptide manufacturing still requires analytical confirmation, documented controls, and human scientific oversight.

Key Regional Insights Across Global Peptide Synthesis Markets

Asia-Pacific is strengthening its role as a peptide synthesis growth engine through expanding pharmaceutical manufacturing in China and India, biologics and specialty drug capabilities in South Korea and Japan, and clinical research infrastructure in Australia. The region benefits from cost-efficient production, a deep supplier base for reagents and intermediates, and increasing domestic demand for diabetes, obesity, oncology, and infectious-disease therapies.

North America remains a high-value center for peptide innovation due to the concentration of biotechnology companies, academic research, venture funding, FDA-regulated development programs, and specialized manufacturing capabilities in the United States and Canada. Latin America, led by Brazil and Mexico, is gaining relevance through branded generics, clinical trial participation, and public-health demand. Europe maintains strong leadership in quality systems, sustainable chemistry, and EMA-aligned GMP manufacturing, while the Middle East is investing in pharmaceutical localization through GCC industrial strategies. Africa is still emerging, with opportunities in diagnostics, antimicrobial research, local fill-finish, and regional supply-chain resilience.

Key Group Insights for Peptide Synthesis Growth Clusters

ASEAN markets are becoming more important to peptide synthesis through Singapore’s biomedical hub, Malaysia’s halal pharmaceutical ecosystem, Thailand’s medical tourism base, and Vietnam and Indonesia’s expanding healthcare demand. These markets are attractive for regional distribution, clinical partnerships, and specialty formulation strategies, although advanced GMP peptide API production remains concentrated in more mature manufacturing clusters.

The GCC is using healthcare diversification and life-science localization programs to reduce import dependence and attract pharmaceutical manufacturing. The European Union provides regulatory harmonization, high-quality manufacturing standards, and strong sustainability requirements that influence global peptide production practices. BRICS countries combine large patient populations with growing API capabilities, while G7 economies remain critical for innovation, intellectual property, premium manufacturing, and reimbursement access. NATO-aligned supply-chain policies are also increasing attention to secure sourcing of APIs, reagents, and critical laboratory materials.

Key Country Insights Shaping Peptide Synthesis Demand

The United States leads peptide synthesis demand through strong biotechnology funding, advanced drug discovery, FDA-regulated clinical pipelines, and commercial peptide API requirements. Canada contributes research depth and clinical development capabilities, while Mexico is increasingly relevant for nearshoring, pharmaceutical packaging, and regional access. Brazil anchors Latin American demand through its large healthcare system and expanding pharmaceutical sector.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support peptide innovation through academic research, specialty pharma, manufacturing networks, and regulated production expertise, while Russia maintains domestic pharmaceutical production priorities under supply-security pressures. China and India are pivotal for API scale, cost competitiveness, and supplier networks; Japan and South Korea emphasize high-quality manufacturing, innovation, and advanced therapeutics; and Australia contributes clinical research, translational science, and Asia-Pacific commercialization pathways.

Actionable Recommendations for Peptide Synthesis Industry Leaders

Industry leaders should prioritize scalable GMP capacity, early process development, and robust analytical control strategies for long, cyclic, modified, and highly potent peptides. Companies that invest in automated synthesis, high-resolution purification, impurity libraries, and digital batch documentation will be better positioned to reduce development risk and support regulatory submissions.

Executives should also diversify critical raw material sourcing, qualify dual suppliers, and build regional manufacturing redundancy to reduce disruption exposure. Strategic partnerships with AI-enabled discovery platforms, specialized manufacturers, resin suppliers, and formulation specialists can shorten timelines, while green chemistry programs focused on solvent reduction and waste management can improve both margins and ESG performance.

Research Methodology for Peptide Synthesis Market Analysis

This executive summary is based on a structured secondary research framework that evaluates peer-reviewed scientific literature, regulatory guidance, public disclosures, clinical development trends, patent activity, trade data, and recognized health and pharmaceutical industry sources. The assessment emphasizes verifiable indicators such as drug approvals, manufacturing investments, GMP requirements, clinical pipeline activity, and regional industrial policy.

Findings were synthesized through triangulation, competitive benchmarking, demand-side analysis, and supply-chain mapping. Insights were validated against known peptide manufacturing constraints, including sequence length, aggregation, impurity formation, purification yield, raw material availability, and regulatory expectations for identity, purity, potency, and stability.

Conclusion: Strategic Outlook for Peptide Synthesis

Peptide synthesis is entering a high-growth phase driven by therapeutic validation, demand for complex biologically active molecules, and the rise of precision medicine. The strongest opportunities are emerging where discovery innovation, GMP manufacturing, analytical excellence, and supply-chain resilience intersect.

Organizations that combine automated peptide synthesis, AI-assisted development, sustainable chemistry, and global regulatory discipline will be best positioned to capture value. As peptide drug pipelines expand, competitive advantage will increasingly depend on speed, quality, scalability, and the ability to manufacture complex sequences reliably at commercial scale.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Peptide Synthesis Market, by Product Type
7.1. Introduction
7.2. Equipment
7.2.1. Chromatography Equipment
7.2.2. Lyophilizers
7.2.3. Peptide Synthesizers
7.3. Reagents & Consumables
7.3.1. Amino Acids
7.3.2. Coupling Reagents
7.3.3. Dyes & Fluroscent Labeling Reagents
7.3.4. Resins
7.4. Services
8. Peptide Synthesis Market, by Technology
8.1. Introduction
8.2. Hybrid Technology
8.3. Liquid Phase Peptide Synthesis
8.4. Solid Phase Peptide Synthesis
9. Peptide Synthesis Market, by Application
9.1. Introduction
9.2. Cosmetics
9.3. Diagnosis
9.4. Research & Development
9.5. Therapeutics
10. Peptide Synthesis Market, by End-User
10.1. Introduction
10.2. Academic Research
10.3. Clinical Laboratories
10.4. Contract Research Organizations
10.5. Pharmaceutical & Biotech Companies
11. Peptide Synthesis Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Peptide Synthesis Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Peptide Synthesis Market, by Country
13.1. United States
13.2. Germany
13.3. China
13.4. United Kingdom
13.5. India
13.6. Japan
13.7. Russia
13.8. Brazil
13.9. Canada
13.10. Italy
13.11. Mexico
13.12. France
13.13. Spain
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 2B Scientific Limited
15.2. AAPPTec LLC
15.3. ABclonal, Inc.
15.4. Advanced ChemTech by Thorn BioScience LLC
15.5. Almac Group Limited
15.6. AmbioPharm Inc.
15.7. AnaSpec Inc.
15.8. Bachem AG
15.9. Biocon Limited
15.10. BioDuro LLC
15.11. Biosynth Ltd.
15.12. Biotage AB
15.13. CEM Corporation
15.14. CPC Scientific Inc.
15.15. Creative Diagnostics
15.16. CSBio Sciences Private Limited
15.17. Enamine Ltd.
15.18. GenScript Biotech Corporation
15.19. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
15.20. JPT Peptide Technologies GmbH by TheraCode GmbH
15.21. Kaneka Corporation
15.22. LifeTein LLC
15.23. Merck KGaA
15.24. New England BioGroup, LLC
15.25. Novo Nordisk A/S
15.26. PolyPeptide Group AG
15.27. Thermo Fisher Scientific Inc.
15.28. USV Private Limited
List of Figures
FIGURE 1. GLOBAL PEPTIDE SYNTHESIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PEPTIDE SYNTHESIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CHROMATOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CHROMATOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CHROMATOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LYOPHILIZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LYOPHILIZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LYOPHILIZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PEPTIDE SYNTHESIZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PEPTIDE SYNTHESIZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PEPTIDE SYNTHESIZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL AMINO ACIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL AMINO ACIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL AMINO ACIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL COUPLING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL COUPLING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL COUPLING REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DYES & FLUROSCENT LABELING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DYES & FLUROSCENT LABELING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DYES & FLUROSCENT LABELING REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RESINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL RESINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL RESINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL HYBRID TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL HYBRID TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL HYBRID TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL COSMETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL COSMETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL COSMETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 78. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 80. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 81. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 82. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 83. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 84. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 85. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 87. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 88. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 89. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 90. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 91. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 92. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 94. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 95. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 96. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 97. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 99. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 101. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 102. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 103. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 104. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 105. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 106. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 108. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 109. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 110. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 111. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 112. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 117. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 118. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 119. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 120. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 121. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 123. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 124. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 125. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 126. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 135. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 138. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 139. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 140. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 142. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 145. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 146. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 147. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 148. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 149. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 151. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 152. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 153. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 158. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 160. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 161. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 162. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 164. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 165. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 166. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 167. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 168. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 171. CHINA PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 172. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 173. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 174. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 175. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 178. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 185. INDIA PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 186. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 188. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 189. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 192. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 193. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 195. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 196. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 197. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 199. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 200. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 202. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 203. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 206. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 209. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 210. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 211. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 213. CANADA PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 214. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 215. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 216. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 217. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 220. ITALY PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 221. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 222. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 223. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 224. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 225. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 227. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 230. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 231. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 232. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 233. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 234. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 236. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 237. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 238. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 239. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 241. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 242. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 244. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 245. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 248. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 250. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 251. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 252. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 253. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 255. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 258. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 259. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 260. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 263. GLOBAL PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • 2B Scientific Limited
  • AAPPTec LLC
  • ABclonal, Inc.
  • Advanced ChemTech by Thorn BioScience LLC
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • BioDuro LLC
  • Biosynth Ltd.
  • Biotage AB
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • CSBio Sciences Private Limited
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 811.94 Million
Forecasted Market Value ( USD ) by 2032 $ 1300 Million
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Automated Parallel Peptide Synthesizer Market - Global Forecast 2026-2032 - Product Image

Automated Parallel Peptide Synthesizer Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
High-throughput Peptide Synthesizer Market - Global Forecast 2026-2032 - Product Image

High-throughput Peptide Synthesizer Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Peptide Synthesis - Global Strategic Business Report - Product Image

Peptide Synthesis - Global Strategic Business Report

  • Report
  • 451 Pages
  • Global
From
Peptide Synthesis Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Peptide Synthesis Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 103 Pages
  • Global
From
Peptide Synthesis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Peptide Synthesis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.